Page 3 - Patrick Claridge News Today

Investegate announcements from Nuformix PLC, Board Changes

Investegate announcements from Nuformix PLC, NXP002 data to be presented at 2022 ERS Congress

Investegate announcements from Immupharma PLC, Admission of new ordinary shares of £0.01

An Arizona lawyer has consented to a two-month suspension after he was accused of using the chat function on GoToMeeting to coach his client during a virtual trial.

Investegate announcements from Immupharma PLC, PROF. SYLVIANE MULLER AWARDED LEGION DHONNEUR

    Blue Star Capital plc (AIM: BLU), the investing company with a focus on esports, payments, technology and its applications within media and gaming, provides a general update in respect of certain of its investee companies.      Guild was admitted to the Official List and started trading on the standard segment of the London Stock Exchange in October 2020 to take advantage of the growing esports markets.  It is Guilds intention to create a leading global esports franchise by establis...

About ImmuPharma PLC ImmuPharma PLC (LSE AIM: IMM - Euronext Growth: ALIMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Companys portfolio includes novel peptide therapeutics for autoimmune diseases, metabolic diseases, anti-infectives and cancer. The lead program, Lupuzor™, is a first-in class autophagy immunomodulator which is in Phase 3 for the treatment of lupus and preclinical analysis suggest therapeutic activity for m...